Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:40 PM
Ignite Modification Date:
2025-12-24 @ 5:40 PM
NCT ID:
NCT01329068
Eligibility Criteria:
Inclusion Criteria:
Participants: patients in follow-up after breast cancer
* Women ≥ 18 years of age with histologically proven breast cancer.
* Primary treatment (surgery, radiotherapy, chemotherapy) completed maximally 5 years ago.
Participants: women with a BRCA mutation
* Women ≥ 25 years of age with a proven BRCA1 or BRCA2 mutation.
* Carrier of a BRCA1 or BRCA2 mutation, diagnosed maximally two years before inclusion.
Exclusion Criteria:
Participants: patients in follow-up after breast cancer
* Metastatic breast cancer
* Currently involved in a diagnostic work-up because of a suspicion of breast cancer, either primary or metastatic.
* A history of prophylactic mastectomy.
* Current psychiatric disease precluding consultations in a group.
* Insufficient command of the Dutch language to be able to follow a group discussion and/or to fill out a Dutch questionnaire
Participants: women with a BRCA mutation
* Metastatic breast cancer
* Currently involved in a diagnostic work-up because of a suspicion of breast cancer, either primary or metastatic.
* A history of prophylactic mastectomy.
* Current psychiatric disease precluding consultations in a group.
* Insufficient command of the Dutch language to be able to follow a group discussion and/or to fill out a Dutch questionnaire
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT01329068
Study Brief:
Protocol Section:
NCT01329068